New patent expiration for Takeda Pharms drug OSENI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for OSENI
Annual Drug Patent Expirations for OSENI

Oseni is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.

OSENI drug price trends.

Drug patent litigation for OSENI.

This drug has one hundred and sixty-two patent family members in forty-five countries.

The generic ingredient in OSENI is alogliptin benzoate; pioglitazone hydrochloride. Two suppliers are listed for this compound. Additional details are available on the alogliptin benzoate; pioglitazone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top